Search - tctmd.com

Displaying 121 - 140 of 665

Sort: Relevancy | Date

Presentation TCT 2017

EVOLUT R Procedural Pearls (Including how NOT to Need a New Pacemaker)

Presenter: Hemal Gada

October 31, 2017

Presentation TCT 2017

Valve Degeneration and Leaflet Mobility Considerations: Assessing Clinical Relevance

Presenter: Martin B. Leon, Changfu Wu, Lars Sondergaard

October 31, 2017

Presentation TCT 2017

EVOLUT R TAVR Technology Review (Including EVOLUT 34mm and PRO) and Clinical Program Updates

Presenter: John K. Forrest

October 31, 2017

Presentation TCT 2017

Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences

Presenter: Martin B. Leon, Changfu Wu

October 31, 2017

Presentation TCT 2017

SAPIEN 3 Procedural Pearls (Including Optimal Sizing Algorithms)

Presenter: Susheel K. Kodali

October 31, 2017

Presentation TCT 2017

SAPIEN 3 TAVR Technology Review (Including Sapien 3 ULTRA) and Clinical Program Updates

Presenter: John G. Webb

October 31, 2017

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

Presentation TCT 2017

Industry Perspective on Real-World Evidence for TAVR Outcomes Where are the Opportunities?

Presenter: Martin B. Leon, Changfu Wu, Larry L. Wood

October 31, 2017

Presentation TCT 2017

Case #2: Double Aortic and Mitral Transcatheter Valve Replacement Using Innovative Bioprostheses

Presenter: João AB Brum Silveira, Marcelo Jose de Carvalho Cantarelli, Henrique B. Ribeiro

October 31, 2017

Presentation TCT 2017

TCT 40: Outcome Of Patients Undergoing Trans-Catheter Implantation of Aortic Valve With Previous Mitral Valve Prosthesis (Optimal Study)

Presenter: Jean-Claude Laborde, Eric Van Belle, Luca Baldetti, MD

October 31, 2017

Presentation TCT 2017

TCT 39: Clinical Outcomes in SURTAVI Based on Revascularization Stratification

Presenter: Jean-Claude Laborde, Eric Van Belle, Lars Sondergaard

October 31, 2017

Presentation TCT 2017

TCT 38: Self-Expanding TAVR for Treatment of Aortic Insufficiency: An Analysis of the STS/ACC TVT Registry

Presenter: Jean-Claude Laborde, Eric Van Belle, Saif Anwaruddin

October 31, 2017

Presentation TCT 2017

TCT 30: Instantaneous Wave-Free Period Variations after Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis

Presenter: Justin E. Davies, Bernard De Bruyne, Gabriele Pesarini, MD

October 31, 2017

Presentation TCT 2017

TCT 37: Sudden Cardiac Death in Patients With Severe Aortic Stenosis

Presenter: Jean-Claude Laborde, Eric Van Belle, Tomohiko Taniguchi, MD

October 31, 2017

Presentation TCT 2017

MARE: Ambulatory Electrocardiographic Monitoring With an Implantable Loop Recorder in Patients With New-Onset Persistent LBBB After TAVR

Presenter: Y. S. Chandrashekhar, David J. Moliterno, Josep Rodés-Cabau

October 31, 2017

Presentation TCT 2017

TCT 52: Novel Preclinical Assessment of Transcatheter Mitral Valve Replacement by Micro-Computed Tomography: µCT Imaging-Guided Histopathological Evaluation

Presenter: Peter C. Block, Lars Sondergaard, Armando Tellez, MD

October 31, 2017

Presentation TCT 2017

TCT 36: Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement

Presenter: Reginald I. Low, Michael J. Rinaldi, Richard Jabbour

October 31, 2017

Presentation TCT 2017

TCT 91: Antithrombotic Therapy Post Transcatheter Aortic Valve Replacement in Patients With No Indication for Anticoagulation

Presenter: Kurt Huber, Jamil Abdalla Saad, Dimitrios Alexopoulos, Antonio L. Bartorelli, Bjorn Redfors, Carlos E. Uribe

October 31, 2017

Presentation TCT 2017

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

Presenter: Peter C. Block, Lars Sondergaard, Tarun Chakravarty, MD

October 31, 2017

Presentation TCT 2017

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

Presenter: Reginald I. Low, Michael J. Rinaldi, Julia Seeger

October 31, 2017

Advertisement

EVOLUT R Procedural Pearls (Including how NOT to Need a New Pacemaker)

Valve Degeneration and Leaflet Mobility Considerations: Assessing Clinical Relevance

EVOLUT R TAVR Technology Review (Including EVOLUT 34mm and PRO) and Clinical Program Updates

Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences

SAPIEN 3 Procedural Pearls (Including Optimal Sizing Algorithms)

SAPIEN 3 TAVR Technology Review (Including Sapien 3 ULTRA) and Clinical Program Updates

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Industry Perspective on Real-World Evidence for TAVR Outcomes Where are the Opportunities?

Case #2: Double Aortic and Mitral Transcatheter Valve Replacement Using Innovative Bioprostheses

TCT 40: Outcome Of Patients Undergoing Trans-Catheter Implantation of Aortic Valve With Previous Mitral Valve Prosthesis (Optimal Study)

TCT 39: Clinical Outcomes in SURTAVI Based on Revascularization Stratification

TCT 38: Self-Expanding TAVR for Treatment of Aortic Insufficiency: An Analysis of the STS/ACC TVT Registry

TCT 30: Instantaneous Wave-Free Period Variations after Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis

TCT 37: Sudden Cardiac Death in Patients With Severe Aortic Stenosis

MARE: Ambulatory Electrocardiographic Monitoring With an Implantable Loop Recorder in Patients With New-Onset Persistent LBBB After TAVR

TCT 52: Novel Preclinical Assessment of Transcatheter Mitral Valve Replacement by Micro-Computed Tomography: µCT Imaging-Guided Histopathological Evaluation

TCT 36: Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement

TCT 91: Antithrombotic Therapy Post Transcatheter Aortic Valve Replacement in Patients With No Indication for Anticoagulation

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content